The Food and Drug Administration (FDA) announced that Desferal (deferoxamine mesylate for injection; Novartis) 2g vials are being discontinued as of September 2015. The reason for the discontinuation ...

Teva Pharmaceutical Industries has been given a green light to sell a generic version of Novartis’ iron overload treatment Desferal in the USA. Teva Pharmaceutical Industries has been given a green ...

Three recent studies comparing oral iron chelators deferiprone (Ferriprox, Apotex) and deferasirox (Exjade, Novartis) with deferoxamine (Desferal, Novartis) suggest that the oral chelators clear iron ...

Novartis has assured that steps are being taken to ensure the adequate supply of Desferal, a drug crucial for treating iron overload in Thalassemia patients. The drug is manufactured exclusively by ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Deferoxamine (Desferal (500 mg)) is an ...

Thalassemia patients are struggling to access Desferal, with many government hospitals lacking the drug despite its critical role in managing iron overload from blood transfusions. NEW DELHI: ...

Review the side-effects of Deferoxamine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Earlier this week, a petition addressed to Health Minister JP Nadda raised concerns over the “non-availability” of Desferal, an injectable drug used to reduce excess iron in the blood for people with ...

MITEM PHARMA, the pharmaceutical laboratory based in France and dedicated to Medicines of Major Therapeutic Interest (M.I.T.M.), is pleased to announce the worldwide acquisition of DESFERAL®, a major ...

For about one month now, 19-year-old thalassemia patient Afsana Ahmed*, from Bangalore, has not been administered an injectable drug that removes excess iron accumulated in her body as a result of ...